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Spinal cord injury (SCI) activates circulating leukocytes that migrate into the injured cord and
bystander organs using adhesion molecule-mediated mechanisms. These cells cause oxidative
damage, resulting in secondary injury to the spinal cord, as well as injury to bystander organs.
This study was designed to examine, over a 6-h to 2-week period, changes in adhesion molecule
surface expression on human peripheral leukocytes after SCI (9 subjects), using as controls 10
uninjured subjects and 6 general trauma patients (trauma controls, TC). Both the percentage of
cells expressing a given adhesion molecule and the average level of its expression was quantified
for both circulating neutrophils and monocytes. The percentage of neutrophils and monocytes
expressing the selectin CD62L was unchanged in TC and SCI patients after injury compared to
uninjured subjects. Concurrently, the amount of surface CD62L on neutrophils was decreased in
SCI and TC subjects, and on monocytes after SCI. The percentage of neutrophils expressing α4
decreased in TC, but not in SCI, subjects. Likewise, the percentage of neutrophils and monocytes
expressing CD11d decreased markedly in TC subjects, but not after SCI. In contrast, the mean
surface expression of α4 and CD11d by neutrophils and monocytes increased after SCI compared
with uninjured and TC subjects. The percentage of cells and surface expression of CD11b were
similar in neutrophils of all three groups, whereas CD11b surface expression increased after SCI
in monocytes. In summary, unlike changes found after general trauma, the proinflammatory
stimulation induced by SCI increases the surface expression of adhesion molecules on circulating
neutrophils and monocytes before they infiltrate the injured spinal cord and multiple organs of
patients. Integrins may be excellent targets for anti-inflammatory treatment after human SCI.
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Spinal cord injury (SCI) induces immediate damage to neuronal cell bodies and axons as
well as glia, which is followed by progressive, secondary damage at and near the injury site
(Blight, 1992; Fleming et al., 2006). This secondary damage exacerbates the functional
losses of the SCI patient. Inflammation in the injury site after SCI plays an important role in
secondary cell death (Blight, 1985; Taoka and Okajima, 1998; Tator and Fehlings, 1991;
Young, 1993). The hallmark of the inflammatory reaction to SCI is the large numbers of
leukocytes that invade the injured spinal cord (Blight, 1992; Fleming et al., 2006; Saville et
al., 2004), and bystander organs such as the lungs and kidneys (Gris et al., 2008). In
response to stress or injury, leukocytes are released into the blood from marginal pools and
the bone marrow (Dimitrov et al., 2010; Steppich et al., 2000), increasing the number of
cells available to participate in inflammation-associated secondary injury in the central
nervous system (CNS) lesion, and elsewhere in the body. Upon activation in the circulation,
leukocytes can upregulate expression of their oxidative enzymes (Bao et al., 2009). Such
activation readies the cells for even greater pro-inflammatory and oxidative activity once
they enter an injury site such as a spinal cord lesion (Longbrake et al., 2007; Saiwai et al.,
2010). The potential to infiltrate and cause damage to the spinal cord and other organs
relates to the maturity of the leukocytes and their expression of various integrins and
receptors. Further knowledge of these aspects of circulating human neutrophils and
monocytes after SCI is key to devising treatments that limit their role in secondary SCI
damage.
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Leukocyte migration out of the bloodstream into the sites of inflammation entails a sequence
of leukocyte–adhesion molecule interactions with endothelial cell and extracellular matrix
ligands (Bevilacqua, 1993). Different groups of adhesion molecules mediate this cell–cell
and cell–extracellular matrix adhesion. Migration of neutrophils or monocytes into tissues is
regulated by specific combinations of adhesion receptors and chemoattractants. L-selectins
(CD62L) are transmembranous glycoproteins that recognize carbohydrate residues on
endothelial cells (Springer, 1990). Selectins are the first molecules involved in the
extravasation of leukocytes, as they transiently attach leukocytes to inflamed endothelial
cells, slowing their travel within the blood vessel and commencing a process known as
“rolling” (Bevilacqua et al., 1991). This receptor is known to be shed after ligation
(Bevilacqua, 1993), a process that permits rolling at optimal velocities, an important
determinant of leukocyte recruitment (Hafezi-Moghadam and Ley, 1999). After selectins
initiate the first leukocyte attachment to the vascular endothelium, the next step in leukocyte
migration is tethering and firm adhesion, mediated by membrane-bound integrin molecules.
Upon recognition of inflammatory signals, neutrophils and monocytes are activated to
increase surface expression of integrins (Albelda et al., 1994; Granger and Kubes, 1994;
Hogg and Berlin, 1995), enabling the cells to stop rolling, bind to the endothelium, and
migrate rapidly between endothelial cells into neighboring tissue (Adams and Shaw, 1994;
Kansas, 1996). The leukocyte integrin, α4β1 (CD49d/CD29 or very late antigen-4
[VLA-4]), plays a role in leukocyte rolling and firm adhesion to vascular walls, and also has
important roles in leukocyte activation and migration into tissue (Davenpeck et al., 1998;
Nandi et al., 2004; Yednock et al., 1995). It also facilitates leukocyte adhesion to the
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vascular endothelium and to CNS matrix proteins, while activating cell-signaling pathways
and upregulating β2 integrin expression. Ligation of α4β1 also induces production of
reactive oxygen species by neutrophils (Alon et al., 1995; Poon et al., 2001; van den Berg et
al., 2001).
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The β2 integrins also have an important role in leukocyte migration into tissues, and are
required for the spreading of firmly-attached leukocytes on the endothelial cell surface
(Luscinskas et al., 1994). The β2 integrin CD11b/CD18 (Mac-1) is the most abundant and is
important for neutrophil and monocyte adhesion to endothelial cells (Carlos and Harlan,
1994). The more recently discovered CD11d/CD18 is expressed on neutrophils and
monocyte/macrophages, and binds to vascular cell adhesion molecule-1 (VCAM-1) in rats,
and to induced endothelial cell adhesion molecule-3 (ICAM-3) and VCAM-1 in humans,
facilitating firm adhesion to extracellular matrix molecules (Grayson et al., 1998; Van der
Vieren et al., 1999; Van der Vieren et al., 1995). Leukocyte migration is an important
mechanism in the pathogenesis of inflammatory disease. Thus, blocking leukocyte migration
may have therapeutic potential against inflammation and associated diseases. Indeed, several
studies in animals have shown beneficial effects of such blockade on neurological outcomes
after SCI (Fleming et al., 2008; Gris et al., 2004; Oatway et al., 2005; Taoka and Okajima,
1998).
Although experimental animals have been studied in detail, the human inflammatory
response to SCI is less well understood, especially in the acute period immediately after
injury (Fleming et al., 2006; Yang et al., 2004). Accordingly, we used flow cytometry to
characterize the ensuing cellular inflammatory response in the blood caused by human SCI,
and examined changes in the expression of key adhesion molecules present on circulating
neutrophils and monocytes after SCI.

Methods
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These studies were approved by the University of Western Ontario Research Ethics Board
for the Review of Health Sciences Research Involving Human Subjects. Venous blood
samples were obtained from 25 subjects, of whom 6 were female and the remainder were
male (Table 1). The groups included 10 uninjured subjects (aged 30–60 years), 9 cordinjured subjects (aged 20–87 years), and 6 trauma controls (aged 22–54 years). Patients were
enrolled after obtaining consent at the Robarts Research Institute (uninjured subjects) or
London Health Sciences Centre (trauma controls and cord-injured subjects), London,
Ontario. Exclusion criteria for our study included a personal or family history of peripheral
neuropathy or autoimmune disease, significant cognitive limitations, a history of malignant
cancer within 5 years prior to the study, chronic liver disease, regular medication with antiinflammatory drugs, diseases of the blood, and pregnancy or lactation. If a subject enrolled
in the study required a blood transfusion (typically during surgery, at about 24–48 h after
injury), then no further samples were obtained from that patient. One SCI subject died at 60
h after injury. The blood samples were taken at 6, 12, 24, 48, and 72 h after injury, as well as
at 1 week and 2 weeks after injury. The SCI involved exclusively cervical segments in three
cases, exclusively thoracic segments in three cases, and exclusively lumbar segments in two
cases. One subject had injury to both cervical and lumbar segments. The SCI subjects did
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not have significant other injuries and were not considered to have multi-system trauma. The
trauma controls had significant fractures of the vertebrae (n =2), or long bones (n =4),
without CNS injury or multi-system trauma. The causes of injury for these patients were
motor vehicle accidents or falls. Details about the patients are shown in Table 1.
Flow cytometry study of neutrophils and monocytes
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Blood samples from the uninjured, trauma control, and SCI subjects were analyzed by flow
cytometry. Heparinized whole blood samples were incubated with 5% normal human IgG
for 30 min to block nonspecific antibody binding. Next the samples were incubated with
fluorochrome-labeled antibodies, including isotype-matched mAbs for 15 min in the dark at
4°C. Leukocytes were isolated by ammonium chloride lysis of red blood cells. Cellassociated fluorescence was determined following the immunostaining using a FACSCalibur
flow cytometer (Becton Dickinson, San Jose, CA). At least 50,000 events were analyzed for
each blood sample. Neutrophils and monocytes were initially gated by their characteristic
forward- and side-scatter profiles that represent size and granularity of the cells, respectively
(see CD62L in Fig. 1A). The total population of cells within the gate was distributed as a
scatterplot of fluorescence intensity versus side-scatter to determine the percentage of
neutrophils and monocytes expressing a specific antigen (Fig. 1B and C). Gating for this
analysis was derived from the fluorescence pattern of the isotype-matched control antibody.
In the figures included here, the example of the percentage data and statistical analysis of the
percentage data will typically correspond to the sample time at which the first significant
changes in mean fluorescence intensity (MFI) occurred. The percentage data within the 12–
72 h samples after the injuries were similar.
Separately, the MFI, a measure of overall intensity of surface expression of the phenotypic
markers, was determined for the total population of cells in each respective gate (Fig. 1B and
C). For calculation of the MFI, areas under a histogram of cell number versus fluorescence
were obtained, and then normalized by subtracting the area of fluorescence for the isotypematched control antibody. Background fluorescence in the absence of antibody was typically
1–2% of the mean channel fluorescence of each antigen tested, whereas fluorescence in the
presence of the control mAb ranged from 5–25%. These analyses were performed using
FlowJo software (Tree Star Inc., Ashland, OR).
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Antibodies used in the study
To detect adhesion molecules expressed by the human leukocytes, the following mouse
monoclonal antibodies (mAbs) and their isotype-matched control mAbs were used: APCconjugated mouse anti-human CD62L mAbs, and APC-conjugated mouse IgG1, κ
monoclonal immunoglobulin isotype control; PE-Cy5 conjugated mouse anti-human α4
(CD49d) mAbs, and PE-Cy5 conjugated mouse IgG1, κ monoclonal immunoglobulin
isotype control; Alexa Fluor 488-conjugated mouse anti-human CD11b/Mac-1 mAbs, and
Alexa Fluor-488 conjugated mouse IgG1, κ monoclonal immunoglobulin isotype control (all
from BD Biosciences, Toronto, ON). The Alexa Fluor 488-conjugated mouse anti-human
CD11d mAbs and Alexa Fluor 488-conjugated isotype control 1B7 were gifts from the
former ICOS Corp. (mAbs currently owned by Eli Lilly & Co., Indianapolis, IN).

J Neurotrauma. Author manuscript; available in PMC 2016 April 29.

Bao et al.

Page 5

Statistical analysis

CIHR Author Manuscript

Data are expressed as the mean±standard error (SE). Differences among groups were
established using one-way analysis of variance (ANOVA), and post-hoc Fisher’s protected ttests (Sokol and Rohlf, 1981). Sequential data collected during the first 72 h after SCI were
compared to those of the uninjured subjects in a separate analysis from the values collected
at 1 and 2 weeks after SCI, due to the smaller number of subjects available at the 1- and 2week time points. Use of a two-way ANOVA was not possible, as time was shown not to be
a significant factor in most of the measurements. Statistical significance was set at p <0.05.
Details of the ANOVA results are given in the text. Statements of significance assume p
≤0.05 by Fisher’s protected t-tests.

Results
Adhesion molecule expression by neutrophils and monocytes
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L-selectin (CD62L)—Examples of scatterplots of CD62L surface expression on
neutrophils are shown in Figure 2A. These plots are representative of the CD62L expression
by neutrophils of an uninjured subject, and of trauma control and SCI subjects, at 24 h after
injury. Background fluorescence generated by the isotype control mAb is also shown. The
majority of the neutrophils in the blood of uninjured subjects were CD62L-positive, with 86
± 10% of the cells expressing this molecule (Fig. 2A). At 24 h after injury, the percentages
of neutrophils expressing CD62L in trauma controls (82 ± 11%) and in SCI subjects (83
± 8%) were similar to those of uninjured subjects. In contrast, the level of CD62L surface
expression on positive neutrophils, as shown by the MFI, was uniformly reduced in the
trauma control and SCI subjects throughout the time course of the study compared to that in
uninjured subjects. The average MFI for all patients in the trauma control and SCI groups
(Fig. 2C) was significantly lower than that of uninjured subjects at almost all time points
sampled, with the exception of a return to the uninjured range by 2 weeks post-SCI
(ANOVA, 6–72 h, F10,41 = 2.02, p =0.037; 1–2 week, F4,13 = 3.87, p =0.028). CD62L
expression in trauma controls did not differ from that in SCI subjects.
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A high percentage of monocytes (70 ± 12%) in the uninjured subjects were CD62L-positive
(Fig. 2B). At 24 h after injury, this percentage was similar in the trauma controls (70 ± 12%)
and SCI (61 ± 10%) subjects. Quantitative assessment of the average MFI in the SCI and TC
groups revealed decreased CD62L surface expression on CD62L-positive monocytes of TC
subjects only at 6 h and 2 weeks after injury (Fig. 2D), compared to the uninjured subjects,
whereas decreases in SCI subjects occurred at all sampling times except 2 weeks (ANOVA,
6–72 h, F10,41 = 2.8, p =0.026; 1–2 week, F4,13 = 4.37, p =0.019). The SCI and TC groups
did not differ from each other.

α4 Subunit of the α4β1 integrin—In uninjured subjects, 36 ± 7% of neutrophils
expressed the α4 subunit of the α4β1 integrin (Fig. 3A). At 24 h after injury, only 13 ± 4%
of neutrophils of trauma controls expressed α4, whereas after SCI 32 ± 9% of neutrophils
expressed this integrin subunit. Although this decrease in TC subjects did not achieve
significance when all three groups were compared with an ANOVA (F2,16 = 2.31, p =0.131),
a comparison between the two groups (uninjured and trauma controls) demonstrated a
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significant difference (F1,9 = 8.61, p =0.017). When the average MFI on positive neutrophils
was examined, α4 surface expression (Fig. 3C) decreased significantly in trauma controls
throughout the early sampling periods (6–72 h) and at 1 week after injury, compared to that
seen in uninjured subjects (ANOVA, 6–72 h, F10,56 = 7.313, p <0.001; 1–2 weeks, F4,19 =
4.085, p =0.015). Thus the number of α4-positive neutrophils was reduced in trauma
controls, and those neutrophils that were positive expressed lower levels of α4 on their
surface. In contrast, surface expression of α4 on positive neutrophils was increased after SCI
compared to levels in uninjured subjects, at 12 h, 24 h, and 1 week after injury. This
expression was also significantly different from that seen in trauma controls from 12–72 h
and at 1 week after injury.
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Most monocytes (95 ± 2%) showed surface expression of α4 with a frequency that was not
significantly different between trauma control and SCI subjects (Fig. 3B). At 24 h after
injury 85 ± 8% of monocytes in trauma controls and 84 ± 6% of monocytes in SCI subjects
expressed this integrin subunit. Despite the similar percentages of monocytes expressing the
α4 integrin in the three groups, the average MFI for α4 on the surface of monocytes of
trauma controls was significantly less than that of uninjured subjects from 6 h to 1 week
after injury (Fig. 3D; ANOVA, 6–72 h, F10,56 = 4.377, p <0.001; 1–2 weeks, F4,19 = 4.972, p
=0.006). In contrast, based on MFI, the surface expression on α4-positive monocytes of SCI
patients was no different from that of uninjured subjects, and furthermore, from 24 h to 1
week after injury, the monocyte α4 surface expression in SCI subjects was significantly
greater than in trauma controls.
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CD11d subunit of the β2 integrin CD11d/CD18—Uninjured subjects and subjects at
48 h after SCI exhibited very similar percentages of CD11d-positive neutrophils (32 ± 9%
and 35 ± 11%, respectively), but the percentage of CD11d-positive neutrophils was greatly
reduced (7 ± 2%) in trauma controls (ANOVA, F2,15 = 3.53, p =0.05; Fig. 4A) at 24 h postinjury. The MFI for surface expression on CD11d-positive neutrophils of uninjured, TC, and
SCI subjects, was generally low at all time points except at 2 weeks after SCI, when it
increased substantially (Fig. 4C). Surface expression of CD11d on positive neutrophils from
trauma controls was approximately constant throughout the time course of this study.
Despite the lowered number of neutrophils expressing CD11d in the trauma controls, the
MFI for those cells was similar to that of uninjured subjects. In contrast, neutrophil CD11d
surface expression after SCI generally tended to be increased compared to uninjured
controls, reaching a significant 42% increase by 48 h after SCI, and a substantial (~6-fold)
increase at 2 weeks (ANOVA, 6–72 h, F10,55 = 2.50, p =0.015; 1 and 2 weeks, F4,18 = 3.83,
p <0.02). At 12–48 h after injury the MFI of CD11d surface expression in SCI subjects was
significantly greater (~2-fold) than in trauma controls, and at 2 weeks this difference was
even more substantial (~7-fold).
The majority of monocytes (77 ± 2%) in uninjured subjects expressed CD11d, and again the
percentage was decreased in the TC subjects (Fig. 4B). For example, at 48 h after injury in
TC subjects, 41 ± 10% of monocytes expressed CD11d, and this percentage was
significantly lower than in uninjured (77 ± 2%) and SCI (77 ± 3%) subjects (ANOVA, F2,15
= 10.82, p =0.0012). Despite the decreased numbers of monocytes expressing CD11d in
trauma controls, mean fluorescence did not differ from that in uninjured subjects, and
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remained relatively constant throughout the time course of the study (Fig. 4D). In SCI
subjects, CD11d surface expression on positive cells was greater than in uninjured controls,
by 34% and 42% at 12 and 48 h, and by sevenfold at 2 weeks after injury (ANOVA, 6–72 h,
F10,55 = 6.014, p <0.001; 1 and 2 weeks, F4,18 = 3.891, p <0.019). At 12–48 h after SCI, the
surface expression of CD11d on positive monocytes was about twice that of trauma controls
(significantly greater) and, similarly to neutrophil expression, this difference was even larger
at 2 weeks (Fig. 4D).
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The CD11b subunit of the β2 integrin CD11b/CD18—The CD11b subunit of the β2
integrin CD11b/CD18 is expressed on the surface of nearly all neutrophils and monocytes
(Fig. 5A and B). Most neutrophils (Fig. 5A) in the blood of uninjured subjects surface
expressed CD11b (97 ± 1%). This prevalence was very similar in trauma controls (99 ± 0%),
and SCI subjects (100 ± 0%), at 24 h after injury. When the MFI was analyzed, the average
expression of CD11b on positive neutrophils of trauma controls and SCI subjects at 6–72 h
after injury (Fig. 5C) was no different from that of uninjured subjects, although a tendency
toward increased expression was noted after SCI (ANOVA, F10,51 = 1.44, p =0.19). The
CD11b surface expression on positive neutrophils at 1 week after SCI was significantly
greater, by fourfold, than on neutrophils of uninjured and trauma control subjects (ANOVA,
F4,17 = 11.682, p <0.001). When CD11b MFI from all seven sampling times were averaged,
the CD11b expression on neutrophils of SCI subjects was significantly greater than that of
uninjured and trauma controls (ANOVA, F2,16 = 11.77, p <0.001), but no differences were
found between trauma controls and uninjured subjects.
Most monocytes (Fig. 5B) in uninjured subjects also exhibited CD11b surface expression
(95 ± 2%). Again, this prevalence was similar in trauma controls (97 ± 1%) and SCI subjects
(98 ± 1%) at 24 h after injury. The monocyte CD11b MFI was significantly greater, by oneto threefold, in SCI subjects than in uninjured subjects at 12–48 h, and at 1 and 2 weeks after
injury (ANOVA, 6–72 h, F10,51 = 2.459, p =0.017; 1 and 2 weeks, F4,17 = 7.941, p <0.001;
Fig. 5D). CD11b surface expression on monocytes from trauma controls did not change. At
24 h, 48 h, and 1 week post-injury, the surface expression of CD11b was significantly
greater in SCI subjects than in trauma controls.
Summary of results
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As described in detail above, after either general trauma or SCI, changes in adhesion
molecule expression generally occurred within 24–48 h after injury. Surface expression of
CD62L usually decreased in TC and SCI subjects. Expression of the integrins often
decreased after general trauma and increased after SCI. The observed changes were more or
less maintained for the 72 h after injury, often lasting up to 2 weeks. Sharp increases in
expression of the two β integrins occurred in the 1- to 2-week period relative to both the
uninjured and TC subjects. To facilitate comparisons between the adhesion molecules, a
summary of these data for the 24–48 h period is presented in Table 2.

Discussion
Our study shows, for the first time in human subjects, that the surface expression of adhesion
molecules on circulating neutrophils and monocytes is changed after SCI. The expression of
J Neurotrauma. Author manuscript; available in PMC 2016 April 29.
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the selectin CD62L decreased to a similar degree after general trauma and SCI, suggesting
that trauma is the common cause of this response. In contrast, the responses of the integrins
α4β1, CD11d/CD18, and CD11b/CD18 differed between general trauma and SCI subjects,
indicating a specific role of the cord injury in the response. Surface expression on
neutrophils and monocytes of the integrins studied almost always increased after SCI,
whereas it decreased (α4 and CD11d), or remained essentially unchanged (CD11b), after
general trauma.
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The results of this study show that the high percentage of neutrophils and monocytes
expressing CD62L did not change with injury, but the extent of this expression decreased
markedly on the neutrophils of TC and SCI subjects, and on monocytes of SCI subjects.
Presumably, this decrease reflects shedding of the selectin CD62L that is known to follow
leukocyte activation and transient binding of CD62L to one of its glycoprotein counterreceptors (Bevilacqua et al., 1991). As CD62L is the first adhesion molecule to begin the
process of leukocyte diapedesis, and it responds quickly to the first signs of inflammation,
the similar responses of neutrophils to SCI and general trauma are understandable. Although
monocytes also decreased their surface expression of CD62L after SCI, the reduction seen
after general trauma was inconsistent, suggesting that this molecule is not essential for their
diapedesis after an injury outside the CNS.
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The pattern of the changes in β1 and β2 integrin expression on neutrophils and monocytes
differed between SCI and TC subjects. The mechanism underlying these disparate responses
in SCI and TC subjects is unclear, but likely relates to qualitative and quantitative
differences in the inflammatory responses to the two conditions. Our previous study has
shown, in these same two groups of subjects and at the same sampling times, that SCI causes
more intense activation of the leukocytes than does general trauma (Bao et al., 2009),
impacting both neutrophils and monocytes. An additional factor contributing to the
leukocyte profiles seen after SCI is that activated neutrophils are more long-lived (Gris et al.,
2008). The sustained and even increased α4 surface expression by neutrophils after SCI may
reflect this greater leukocyte activation, with greater recruitment of the receptor to the cell
surface, and perhaps greater expression of the integrin proteins. The greater degree of
leukocyte activation seen after SCI may also explain the increased CD11d and CD11b
surface expression. CD11d requires a much stronger proinflammatory signal for activation
than other β2-integrin family members (Noti et al., 2000). Accordingly, only the enhanced
inflammatory response after SCI may be adequate to trigger increased CD11d expression on
neutrophils and on the marginal pool and circulating monocyte populations. We cannot
explain the greatly increased CD11d surface expression seen at 2 weeks after SCI by any
comorbid condition. The patients in this group did not suffer any clinical evidence of
infection or show any obvious cause for an additional inflammatory response at this time
point.
The decreased surface α4 seen in the leukocytes of TC subjects may be attributable to
internalization of this integrin in the circulation after a ligation to its endothelial receptor that
was insufficient to cause diapedesis. Ligation of α4β1 by antibody binding causes
internalization of this receptor (Leone et al., 2003). Our previous study of these TC subjects
(Bao et al., 2009) demonstrated rather weak activation of neutrophils and monocytes, a
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stimulus less likely to increase CD11d expression as discussed above. The dramatic drop in
the percentage of CD11d-positive neutrophils seen after general trauma may also have been
due to the release from bone marrow into the circulation of relatively immature, unactivated
neutrophils that lack CD11d expression, since most types of trauma initiate a transient
neutrophilia (Gris et al., 2008).
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The pattern of CD11d surface expression on monocytes may also relate to their
heterogeneity. Although most peripheral monocytes are “conventional” CD14+ cells, a
smaller population of proinflammatory CD14lowCD16+ monocytes also exists (Tacke and
Randolph, 2006; Ziegler-Heitbrock, 2007). CD11d is proposed to be expressed primarily on
the CD14lowCD16+ subpopulation, but this contention has not been confirmed (Steppich et
al., 2000). CD11d-expressing proinflammatory monocytes may exit the circulation after
general trauma, are attracted to sites of inflammation, or they may adhere to blood vessel
walls. Indeed, the number of CD11d+ monocytes decreased by ~35% in the TC group,
suggesting that as the CD11d+ cells leave the circulation, the relative proportion of CD11d−
monocytes increases. The apparently conflicting increases in proinflammatory CD11d+
monocytes that have been noted in the circulation occur within minutes of stress or trauma
and last less than 20 min (Dimitrov et al., 2010; Steppich et al., 2000). Therefore the effects
of this mobilization probably would not have been observed in our study. A direct analysis
using polychromatic flow cytometry is required to examine CD11d in the two different
monocyte populations after general trauma and SCI.

CIHR Author Manuscript

We can offer some speculation regarding the cause of the different effects of SCI and general
trauma on surface integrin expression. The enhanced leukocyte response to SCI may occur
because SCI damages crucial CNS feedback systems that control inflammation, whereas
general trauma would likely leave them intact. Recent studies in animal models of SCI show
that trauma to the CNS can lead to inhibition of a cholinergic anti-inflammatory pathway,
resulting in heightened systemic inflammatory responses, especially after cervical or highto-mid-thoracic SCI (Rosas-Ballina and Tracey, 2009). This system limits proinflammatory
cytokine production. Increases in proinflammatory chemokine and cytokine concentrations
that have been observed in the circulation after SCI (Ankeny et al., 2006; Campbell et al.,
2005) would impact greatly on the properties of leukocytes. For example, the unregulated
release of proinflammatory cytokines immediately after injury causes activation and priming
of neutrophils (Kobayashi et al., 2003; Ogura et al., 1999). Such priming was found as early
as 2 h after SCI in one of our studies (Gris et al., 2008). Stimulation by chemokines and
cytokines upregulates neutrophil adhesion molecules, enhancing their ability to migrate
(Sunil et al., 2002; Walzog et al., 1999; Wittmann et al., 2004). The proinflammatory
cytokines and an inflammation-induced release of epinephrine also activate monocytes,
inducing them to migrate from marginal pools, and to adopt a macrophage phenotype when
they reach sites of inflammation (Dimitrov et al., 2010). General trauma would not disrupt
this anti-inflammatory pathway, permitting the TC subjects more capacity to limit the
systemic inflammatory response.
The presence of the α4β1 and CD11d/CD18 integrins on the surface of human neutrophils
and monocytes strengthens the idea that blocking the actions of these adhesion molecules
would be a good strategy to limit early inflammation after SCI. Our previous studies in rats
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have shown that antibodies to the α4 subunit of α4β1, and to the CD11d subunit of
CD11d/CD8 (αDβ2), when administered within 2–6 h after SCI can block migration of
neutrophils and monocytes into the injured cord (Ditor et al., 2006; Fleming et al., 2008;
Gris et al., 2004; Oatway et al., 2005; Saville et al., 2004). The present study shows that
surface expression of each of these key integrins is well maintained or increased on the
circulating leukocytes after SCI, a response consistent with the view that they participate in
cell migration after this CNS injury.

CIHR Author Manuscript

Our data show that the onset of increased surface expression was about 12 h after SCI,
providing a good window of opportunity for clinical treatment. Their basal expression on
leukocytes at 6 h post-SCI would also render them available to an earlier course of
treatment. Maintained surface expression throughout the acute period (72 h) after injury
suggests that they could remain an important target during this time. Although we did
observe increases in integrin surface expression after SCI, this finding does not permit the
conclusion that such an increase is necessary for them to have a functional role in leukocyte
migration after SCI. They may have functioned well without such an increase. Indeed, a key
response of the α4β1 integrin to activation is a conformational change that increases
adhesivity to ligands, suggesting that increased amounts of expression of this integrin may
not be necessary for its function (Yednock et al., 1995). Moreover, the functional
implications of the amount of increase cannot be extrapolated from our data. We found
increases ranging from about 20–100%, and a more detailed study ex vivo would be required
to understand the functional implications of these changes. In contrast, the decreases in
integrin expression that occurred exclusively in the TC subjects might indicate a lessening of
capacity to facilitate leukocyte migration, but that too would require further analysis.

CIHR Author Manuscript

In a rat SCI model, we have studied the effectiveness of different onset times of intravenous
treatment with an anti-CD11d blocking mAb, finding excellent efficacy with a 6-h delay in
treatment, and even good efficacy with a delay of 12 h (Ditor et al., 2006). Although the time
course of the rat inflammatory response cannot be precisely extrapolated to the human
condition, the robust expression of the human integrins in the acute hours after SCI suggests
that they would be available targets for therapeutic interventions. In contrast to the
promising role of an anti-integrin strategy, the loss of the surface CD62L selectin by human
neutrophils and monocytes, presumably due to shedding by the activated cells, makes the
selectins a less ideal target for therapy.

Conclusion
In this study we demonstrated that circulating neutrophils and monocytes not only maintain
their surface expression of adhesion molecules after SCI, but increase it. This response is
significant and is often opposite the response seen after general trauma. The increases
sometimes lasted up to weeks after SCI, at time points when other measures of the immune
system show depression (Campagnolo et al., 1997; Cruse et al., 1996). An examination in a
larger patient population of the inflammatory responses that we found may reveal a means
by which secondary complications can be predicted or detected more readily after SCI.
Moreover, this aspect of the systemic inflammatory response may also provide a target for
the development of acute treatments that provide neuroprotection after SCI.
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FIG. 1.
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An example of flow cytometry analysis of surface protein (CD62L) expression in
neutrophils and monocytes. Expression was detected by fluorescent antibodies to the surface
antigens. Neutrophils and monocytes were gated by their characteristic forward- and sidescatter profiles (A), and then cells in each respective gate (B) were analyzed using two
methods for mean fluorescence intensity (MFI). First, fluorescence was plotted against sidescatter to obtain the percentage of cells expressing the protein (C and E). Background
fluorescence generated by the isotype-matched control antibody (left quadrants) was used to
define the gating for detection of cells expressing the protein (right quadrants). Next,
fluorescence was plotted against cell number and the area under this histogram was used as
MFI (D and F). Again, fluorescence of the isotype-matched antibody was used to determine
background fluorescence. Normalized MFI of each surface protein was calculated by
subtracting the area of background fluorescence from the area of fluorescence of the specific
protein.
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FIG. 2.
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The L-selectin (CD62L) expression on neutrophils and monocytes of uninjured (U), trauma
control (TC), and spinal cord injury (SCI) subjects. Panels A and B illustrate examples of
fluorescence plotted against side-scatter to obtain percentages of neutrophils (A) and
monocytes (B) expressing CD62L. Gating was defined as shown by the fluorescence
generated after incubation with the isotype-matched control antibody (Isotype). The larger
numerals in one of each of the quadrants indicate the percentage of positive cells in that
quadrant. The percentages of neutrophils and monocytes expressing CD62L were similar in
these examples from an uninjured subject (Uninjured), and from a TC and a SCI subject,
obtained 24 h after injury. Averages and typical examples of mean fluorescence intensity
(MFI) in neutrophils and monocytes from the uninjured group, and from the TC and SCI
groups, plotted at 6–72 h, 1 week, and 2 weeks after injury, are shown in panels C and D.
The left panels illustrate mean values from each subject group, plotted at the indicated
sampling times. The right panels show a typical histogram example for each group,
including the isotype control. TC and SCI examples are for 24 h post-injury. Neutrophils
from TC and SCI subjects had decreased CD62L MFI (mean ± standard error) compared to
that of uninjured subjects. Decreases in monocytes were significant at all time points after
SCI, but only at 6 h and 2 weeks in the TC subjects (*p ≤0.05 versus the uninjured group, n
=5). Animal numbers at 6, 12, 24, 48, and 72 h, and 1 and 2 weeks after injury, respectively:
TC: n =4, 5, 5, 5, 4, 3, 3; SCI: n =3, 6, 6, 6, 4, 5, 3.
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FIG. 3.
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The α4 subunit expression on neutrophils and monocytes of uninjured (U), trauma controls
(TC), and spinal cord injury (SCI) subjects. Panels A and B illustrate examples of
fluorescence plotted against side-scatter to obtain percentages of neutrophils (A) and
monocytes (B) expressing α4. The format of this figure is identical to that of Figure 2. The
percentages of neutrophils expressing α4 in this example at 24 h after injury were lower in
the TC than in the uninjured subjects, whereas the SCI subjects were similar to the uninjured
subjects. The percentages of monocytes expressing α4 in the uninjured, TC, and SCI
subjects were similar. Mean fluorescence intensity (MFI) (±standard error) for α4 on
neutrophils and monocytes was decreased in TC subjects compared to uninjured and SCI
subjects, at both early and late sampling times (C and D). In contrast, after SCI, α4 MFI on
neutrophils was increased compared to uninjured and TC subjects. α4 MFI on monocytes
was greater in SCI than TC subjects (*p ≤0.05 versus uninjured subjects; #p ≤0.05 versus
TC subjects; U: n =6 at all time points). Animal numbers at 6, 12, 24, 48, and 72 h, and 1
and 2 weeks after injury, respectively: TC: n =5, 6, 6, 6, 5, 4, 4; SCI: n =4, 8, 8, 8, 5, 6, 4.
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FIG. 4.
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CD11d subunit expression on neutrophils and monocytes of uninjured (U), trauma controls
(TC), and spinal cord injury (SCI) subjects. Panels A and B illustrate examples of
fluorescence plotted against side-scatter to obtain percentages of neutrophils (A) and
monocytes (B) expressing CD11d. The format of this figure is identical to that of Figure 2.
The percentages of neutrophils expressing CD11d in this example at 48 h after injury were
lower in the TC than in the uninjured subjects, and were higher in the SCI subjects. The
percentages of monocytes expressing CD11d in the TC subjects was lower than that in the
uninjured subjects, but in the SCI subjects this percentage was similar to that of the
uninjured subjects. Mean fluorescence intensity (MFI) (± standard error) is shown in panels
C and D. The histogram examples were taken at 48 h after injury. CD11d MFI was not
changed in neutrophils or monocytes of TC subjects compared to uninjured subjects. After
SCI, the CD11d MFI of neutrophils and monocytes was significantly greater than that of
uninjured subjects and TC both at early and late sampling times (*p ≤0.05 versus uninjured
subjects; #p ≤0.05 versus TC subjects; U: n =5). Animal numbers at 6, 12, 24, 48, and 72 h,
and 1 and 2 weeks after injury: TC: n =5, 6, 6, 6, 5, 4, 4; SCI: n =4, 8, 8, 8, 5, 6, 4.
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FIG. 5.

CIHR Author Manuscript

CD11b subunit expression on neutrophils and monocytes of uninjured (U), trauma controls
(TC), and spinal cord injury (SCI) subjects. Panels A and B illustrate examples of
fluorescence plotted against side-scatter to obtain percentages of neutrophils (A) and
monocytes (B) expressing CD11b. The format of this figure is identical to that of Figure 2.
The percentages of neutrophils and monocytes expressing CD11b in these TC and SCI
examples at 24 h after injury were no different from those in the uninjured subjects. Mean
fluorescence intensity (MFI) (±standard error) for CD11b on neutrophils and monocytes was
unchanged in TC subjects compared to uninjured subjects (C and D). CD11b MFI of
neutrophils in SCI subjects was greater than that in uninjured and TC subjects only at 1
week after injury. In monocytes, the CD11b MFI was greater than that of uninjured and TC
subjects at several early and later sampling times (*p ≤ 0.05 versus uninjured subjects; #p ≤
0.05 versus TC subjects; U: n =5). Animal numbers at 6, 12, 24, 48, and 72 h, and 1 and 2
weeks after injury, respectively: TC: n =5, 6, 6, 6, 5, 4, 4; SCI: n =4, 7, 7, 7, 4, 5, 4.
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patient deceased at 60 h after SCI.

at admission;

b

a

AIS, American Spinal Injury; C, cervical; L, lumbar; MVA, motor vehicle accident; T, thoracic;
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TC

SCI

97 ± 1

CD11b

99 ± 0

7±2

13 ± 4

82 ± 11

100 ± 0

35 ± 11

32 ± 9

83 ± 8

TC

97 ± 1
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70 ± 12

12%

18% ↑

111% ↑

69% ↑

1%

42% ↓

TC, trauma control; SCI, spinal cord injury; MFI, mean fluorescence intensity.

All values with the exception of CD11d are illustrated at 24 h after injury. CD11d samples are shown at 48 h.
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